Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

NCT03503799 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1191

Enrollment

OTHER

Sponsor class

Conditions

Primary Invasive Breast Cancer
Estrogen Receptor Positive Tumor
Human Epidermal Growth Factor Receptor 2 Negative Tumor

Interventions

OTHER: Observation

Sponsor

North Eastern German Society of Gynaecological Oncology

Collaborators

[object Object]